A New Paradigm for
Treating CNS Diseases

Inhibikase is a company innovating small-molecule kinase inhibitor therapeutics targeting CNS disease, including diseases of the brain. MORE

Programs focused on reversing the course of neurodegenerative diseases

Programs focused on hematological and gastrointestinal cancers

Programs focused on treating life-threatening brain infections